Evidence map›Paper›PMID 42338940›Full record

ArticleFrontiers in medicine2026

Case Report: Novel

Bin Lin, Li Li, Dong-Kan Li

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Bin Lin *Xiamen Eye Center and Eye Institute of Xiamen University, School of Medicine, Xiamen, China.
Li Li *Xiamen Eye Center and Eye Institute of Xiamen University, School of Medicine, Xiamen, China.
Dong-Kan LiXiamen Eye Center and Eye Institute of Xiamen University, School of Medicine, Xiamen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Juvenile-onset open-angle glaucoma (JOAG) is a heterogeneous early-onset glaucoma subtype. Axenfeld-Rieger syndrome (ARS) is an autosomal dominant disorder caused by Methods: A 15-year-old male proband and his family members received detailed ophthalmic and systemic evaluations. Whole-exome sequencing was performed in the proband, and candidate variants were verified by Sanger sequencing. Bioinformatic tools were used to evaluate variant pathogenicity. Results: The proband and his elder sister initially presented with severe early-onset glaucoma and were diagnosed with JOAG at an outside hospital. After systemic evaluation, they were found to have anterior segment dysgenesis and characteristic facial features, including midface hypoplasia, hypertelorism, and saddle nose deformity, supporting a revised diagnosis of ARS. A novel heterozygous missense variant c.311T>G (p.Ile104Ser) in Conclusion: We identified a novel FOXC1 variant responsible for ARS in a Chinese family. ARS-associated glaucoma can closely mimic JOAG, leading to initial misdiagnosis. The observation of incomplete penetrance in an unaffected carrier father underscores the phenotypic complexity of this disorder. Our findings expand the genotypic spectrum of FOXC1-related disorders and highlight the importance of systemic evaluation and genetic testing in patients with early-onset glaucoma.

Indexed as

Axenfeld-Rieger syndromeFOXC1incomplete penetrancejuvenile-onset open-angle glaucomanovel variantwhole-exome sequencing

Identifiers

PMID42338940
PMCPMC13283791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.